16 Tech District holds great promise

Keywords Opinion

BioCrossroads’ primary mission is to collaborate with Indiana’s corporate, academic, entrepreneurial and philanthropic organizations to foster opportunities and investments in life sciences ideas.

The recently announced 16 Tech District adds a new tool to Indianapolis’ strong life sciences arsenal. This project holds high promise for bringing jobs and mixed-use development to the city’s near-west side, but the realization of this project’s potential depends upon support of public and private entities sharing a passion for the growth of life sciences. We have that support and examples to back it up.

16 Tech is surrounded by some of the world’s finest medical and biotechnology facilities. The Indiana University School of Medicine and the strong bench of research at IUPUI are just blocks away. Combined investment in new state-of-the-art medical facilities in close proximity equals $874 million.

In addition, Indianapolis has twice the nation’s average in bioscience jobs and is one of the nation’s top four life sciences leaders.

It is imperative for organizations to work in concert to foster economic growth. 16 Tech is the latest example of the city’s legacy of private-public collaboration, and again, the cooperation among different groups is outstanding.

Indiana University, Purdue University, Eli Lilly and Co., Roche Diagnostics, Indiana University Health, Dow AgroSciences, and the office of Mayor Greg Ballard are just a few of the stakeholders touting all Indianapolis has to offer companies interested in 16 Tech.

The anticipation that a thriving life sciences district can have significant impact on a neighborhood is evidenced by two projects announced by the city last week—the $22 million renovation of Bush Stadium and the $3 million streetscape project on Indiana Avenue. These projects represent the kind of investment companies seek when deciding where to locate facilities and will serve to spur development in 16 Tech.

BioCrossroads has been a catalyst for our life sciences industry for nearly a decade, and thanks to the collaboration of our partners, we’ve truly begun to put some points on the board.

Now is not the time to pull back. We need to dare to be bold and to focus, not on the next fiscal quarter, but the next quarter century.

16 Tech represents the kind of community-driven strategic thinking that bolsters the vision all of us share for Indianapolis. BioCrossroads is excited to see this vision become reality.


David Johnson
President and CEO

Please enable JavaScript to view this content.

Editor's note: IBJ is now using a new comment system. Your Disqus account will no longer work on the IBJ site. Instead, you can leave a comment on stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Past comments are not currently showing up on stories, but they will be added in the coming weeks. Please note our updated comment policy that will govern how comments are moderated.